US scientists use Chinese humanoid robot for keyhole surgery
Synopsis
Key Takeaways
University of California San Diego (UCSD) researchers have successfully performed keyhole surgery using a general-purpose humanoid robot manufactured by Chinese robotics firm Unitree Robotics, marking a significant step toward autonomous surgical systems. The procedure, conducted on July 10, 2026, saw the robot remove a pig's gallbladder under remote human control — a milestone that researchers say could reshape global access to complex surgical care.
What happened in the operating room
The Unitree Robotics G1 humanoid robot was remotely operated by two human surgeons as it performed a laparoscopic cholecystectomy — the technical term for keyhole gallbladder removal — on a pig at the UCSD campus. A second robot supported the procedure by controlling the endoscope used to visualise the surgical field and retracting tissue as needed. The results were documented in a paper published in Nature.
Why it matters
'Remotely operated and autonomous humanoid robots have real potential for expanding access to critical surgeries that patients might otherwise go without,' said Michael Yip, a professor in UCSD's Department of Electrical and Computer Engineering and senior author of the paper. Yip added: 'This could help address healthcare crises not only in the US, but worldwide.' The use of a general-purpose humanoid — rather than a purpose-built surgical system like the Da Vinci Surgical System — is what sets this experiment apart from prior robotic surgery milestones.
The competitive backdrop
Surgical robotics has long been dominated by specialised platforms, with Intuitive Surgical's Da Vinci system holding a commanding market position. The UCSD experiment, using an off-the-shelf humanoid from Unitree Robotics, signals that general-purpose robots — originally designed for industrial and research applications — may be approaching the precision threshold required for medical use. Researchers involved in the project, including Liang Zekai and Liu Shanglei, are named as contributors to the published work.
What's next
The research team's paper, published in Nature, is expected to draw attention from both the medical robotics industry and regulatory bodies overseeing autonomous surgical systems. The experiment used the codename Surgie for the robotic surgical framework developed at UCSD. Whether this approach can be validated in human trials and cleared by regulators will determine how quickly the technology moves from laboratory to operating theatre.
As humanoid robot capabilities accelerate globally, the race to qualify these platforms for high-stakes medical applications is likely to intensify — with both hardware makers and hospital systems watching closely.